Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,233,718
+$7,306,244 QoQ
Shares Held
903,379
+120.2% QoQ
Ownership
0.855%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. SRPT ranks #45 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,233,718 | 903,379 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,927,474 | 410,270 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,543,460 | 397,001 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $16,044,931 | 832,638 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,163,523 | 243,481 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $13,098,479 | 205,241 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $32,257,702 | 265,299 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $60,217,085 | 482,161 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $60,099,566 | 380,377 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,588,508 | 104,963 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,624,257 | 68,695 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,181,616 | 174,737 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,114,304 | 341,550 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $47,495,250 | 344,593 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $28,620,462 | 220,871 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,206,323 | 173,750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,210,866 | 149,558 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,765,787 | 61,006 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,292,507 | 58,773 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,848,365 | 117,305 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,106,647 | 104,279 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $7,124,917 | 95,598 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $245,741,556 | 1,441,384 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $153,765,230 | 1,094,960 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $187,821,310 | 1,171,394 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $152,077,720 | 1,554,669 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||